A newborn baby enters the world with very low levels of vitamin K, placing them at risk of bleeding problems. Several biological factors explain this vulnerability during the first days of life. First, human placenta is a poor barrier for fat-soluble vitamins, meaning very little vitamin K crosses from the mother to the foetus during pregnancy. Second, a newborn's gut is completely sterile at birth. The friendly intestinal bacteria that normally produce vitamin K in the human body have not yet colonized the digestive tract. Third, breast milk contains relatively low concentrations of vitamin K compared to formula, leaving exclusively breastfed infants dependent on their own meager body stores until they start eating solid foods or develop normal gut flora. These combined factors create a temporary window of deficiency that makes preventive intervention necessary for every neonate.
Without prophylactic supplementation, infants can develop Hemorrhagic Disease of the Newborn (HDN), now more accurately termed Vitamin K Deficiency Bleeding (VKDB). This condition manifests in three distinct clinical forms based on the time of onset:
Administering vitamin K can be achieved through different routes, though intramuscular injection remains the gold standard in Nigerian maternity practice due to absorption reliability.
| Route | Standard Dose | Advantages | Disadvantages |
|---|---|---|---|
| Intramuscular (IM) | 1 mg (0.5 mg for very low birth weight) | Highly reliable absorption, long-lasting protection against late VKDB | Causes localized pain, minor bleeding risk at site |
| Oral | 2 mg repeated at intervals | Non-invasive, avoids injection pain | Requires strict compliance with multiple doses, less reliable absorption |
Midwives must verify the correct formulation, as giving IV vitamin K improperly can cause severe cardiovascular collapse.
In busy Nigerian health facilities, standard protocols dictate that vitamin K should be administered shortly after birth, ideally within the first hour during the golden hour of newborn transition, or delayed until after the first successful breastfeed if skin-to-skin contact is prioritized. The injection is given into the vastus lateralis muscle of the anterolateral thigh using a tuberculin or insulin syringe with a 25-gauge needle. Midwives must cleanse the skin appropriately and stabilize the leg firmly to prevent accidental injury to the sciatic nerve or bone. Documenting the exact time, site, and dosage immediately following administration prevents accidental duplicate dosing by incoming shift staff.
Some parents in Nigerian communities express hesitation or refusal regarding newborn injections due to cultural beliefs, fear of needles, or misinformation gathered from social media regarding vaccine safety. Midwives must approach counseling with empathy rather than judgment. Listen actively to parental concerns, validate their desire to protect their newborn, and explain clearly that vitamin K is a vital nutrient, not a vaccine. Use simple local analogies to explain that the baby's blood needs extra help clotting during the first week of life. If parents remain resistant, document the discussion thoroughly in the case notes and inform the attending physician while continuing respectful engagement.
Proper management of vitamin K extends beyond the injection needle to include safe pharmaceutical storage and accurate record-keeping. Vitamin K ampoules must be stored away from direct sunlight, typically in a cool, dark place or refrigerator according to manufacturer instructions, as ultraviolet light degrades the active compound. Midwives must check expiry dates routinely before drawing up medication. In the clinical register and child health card, documentation must include the brand name, batch number, dose, route, site, date, time, and the signature of the administering midwife to ensure complete traceability.